Crossmark

Radiopharmaceuticals developed for 89Zr-Immuno-PET

Crossref DOI link: https://doi.org/10.1007/s10967-021-07922-6

Published Online: 2021-08-18

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Altıparmak Güleç, Burcu

Yurt, Fatma
License Information

Text and Data Mining valid from 2021-08-18

Version of Record valid from 2021-08-18
More Information

Article History

Received: 13 April 2021

Accepted: 27 July 2021

First Online: 18 August 2021